Novavax, a Covid vaccine manufacturer, has agreed to a $47 million class action settlement
Novavax Coronavirus Vaccine Class Action Settlement Novavax, a pharmaceutical firm that created a Covid vaccine, has agreed to resolve a Class Action lawsuit and establish a $47,000,000 fund to pay back investors who claim Novavax deceived them. The Securities Class Action action, which was first filed in 2021, claims that Novavax deliberately made false statements…